MedPath
TGA Approval

BENDAMUSTINE JUNO bendamustine hydrochloride 25 mg powder for injection vial (321008)

321008

BENDAMUSTINE JUNO bendamustine hydrochloride 25 mg powder for injection vial

Juno Pharmaceuticals Pty Ltd

September 23, 2020

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/0617959cd0198b33653715dc71b3ec7d.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/759bd17e79fb57fdc8b7e147ab14385f.pdf

Active Ingredients

bendamustine hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BENDAMUSTINE JUNO bendamustine hydrochloride 25 mg powder for injection vial (321008) - TGA 批准文号 | MedPath